ReoPro and Retavase to Treat Acute Stroke

NCT00046293 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

NIH

Sponsor class

Conditions

Cerebrovascular Accident

Interventions

DRUG: Reopro
DRUG: Retrovase

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)